Skip to main content
Figure 5 | Stem Cell Research & Therapy

Figure 5

From: Comparative analysis of mesenchymal stem cell and embryonic tendon progenitor cell response to embryonic tendon biochemical and mechanical factors

Figure 5

Comparison of mesenchymal stem cell (MSC) and tendon progenitor cell (TPC) tendon marker gene expression at baseline and with transforming growth factor (TGF)β2 treatment. Comparison of MSC and TPC gene expression at day (D)0 and D3 of TGFβ2 treatment. (A) Comparison of tenogenic gene expression by MSCs versus TPCs at D0; scleraxis (Scx) and elastin (Eln) were significantly lower in MSCs compared to TPCs. At D3 (normalized to D0) of TGFβ2 treatment, (B) Scx, (C) TGFβ2, (D) tenomodulin (Tnmd), and (E) collagen type I (Col I) were not significantly different between MSCs and TPCs, while (F) Eln was significantly higher in TPCs than MSCs. *P < 0.05.

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512